Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03012230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
ClinicalTrials.gov study NCT03358004. IPD Sharing: NO. Countries: 3. Publications: 0.
PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.
ClinicalTrials.gov study NCT06059469. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02750358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06878625. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer
ClinicalTrials.gov study NCT03594396. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04790305. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of an Aerobic Exercise Intervention During Immune Checkpoint Inhibitor Therapy in Early-stage Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07216495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.
ClinicalTrials.gov study NCT04335006. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00951054. IPD Sharing: Not stated. Countries: 1. Publications: 0.
M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03579472. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT04437160. IPD Sharing: NO. Countries: 1. Publications: 0.
Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT05302778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04192903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
ClinicalTrials.gov study NCT05866432. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06162351. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Erlotinib and Metformin in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01650506. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06768931. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT01276769. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06508216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.